Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03990233
Title	A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	OSE Immunotherapeutics
Indications	ovarian cancer colorectal cancer stomach cancer spinal cord lymphoma melanoma lung non-small cell carcinoma triple-receptor negative breast cancer renal cell carcinoma pancreatic cancer head and neck squamous cell carcinoma transitional cell carcinoma Advanced Solid Tumor
Therapies	Effi-DEM Effi-DEM + Ezabenlimab
Age Groups:	adult \| senior
Covered Countries	FRA \| BEL